-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma Confirms €15M Capital Increase Backed By Sanofi To Advance ANKET® Autoimmune Pipeline

Benzinga·04/24/2025 05:51:16
Listen to the news
  • Investment is in addition to the ongoing partnership as shared previously, including continuing the development of BCMA targeting ANKET® program in autoimmune indications, and more